Clinical Trial: A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)

U.S., June 2 -- ClinicalTrials.gov registry received information related to the study (NCT07618325) titled 'A Study to Evaluate the Immune Response Features Following Vaccination With a Recombinant Respiratory Syncytial Virus Vaccine (CHO Cells)' on May 25.

Brief Summary: The purpose of this study is to elucidate the molecular mechanism by which novel adjuvants enhance the immunogenicity of Respiratory Syncytial Virus (RSV) vaccines by regulating antigen-specific B cell affinity maturation and T cell memory formation.

Study Start Date: June 02

Study Type: INTERVENTIONAL

Condition: Respiratory Syncytial Virus (RSV)

Intervention: BIOLOGICAL: Recombinant Respiratory Syncytial Virus Vaccine (CHO Cell)

0.5 mL per dose

Recruitment Status...